Study Details
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
Clinicaltrials.gov ID
Astellas Study ID
5354-CL-0002
EudraCT ID
N/A
Condition
Healthy Volunteer
Phase
Phase 1
Age
20 Years - 44 Years
Sex
Male
Product
ASP5354
Type
Interventional
Trial Dates
Jun 2021 - Jul 2021
Masking
Double (Participant, Investigator)
Enrollment number
12
A Phase 1 Single Intravenous Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants? Contact us by filling our your information to the right and we’ll respond to you.
Locations
JP81001
Sumida-ku, Japan